Berman Capital Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$0	Buy	+2	New	–	﹤0.01%	2227
2020 Q3	–	Sell	-24	Closed	-$5K	–	1770
2020 Q2	$5K	Buy	+24	New	+$5K	﹤0.01%	997